(6?)-17-(Acetyloxy)-6-methyl-pregn-4-ene-3,20-dione-13C2-d3; 17?-Acetoxy-6?-methylpregn-4-ene-3,20-dione-13C2-d3; 17?-Acetoxy-6?-methylprogesterone-13C2-d3; 17?-Hydroxy-6?-methylprogesterone Acetate-13C2-d3; Meprate-13C2-d3; Metigestrona; NSC 21171; NSC 26386; Nadigest; Nidaxin; Novo-Medrone-13C2-d3; Oragest-13C2-d3; Perlutex-13C2-d3; Perlutex Leo-13C2-d3; Prodasone-13C2-d3; Progespon-13C2-d3; Progestalfa-13C2-d3; Progeston-13C2-d3; Progevera-13C2-d3; Provera-13C2-d3; Proverone-13C2-d3; Ralovera-13C2-d3; Repromap-13C2-d3; Repromix-13C2-d3; Sirprogen-13C2-d3; Sodelut G-13C2-d3; Veramix-13C2-d3; Megestrol Acetate EP Impurity A-13C2-d3;Medroxyprogesterone acetate-13C2-d3
Medroxyprogesterone acetate-13C2-d3 is a fully characterized chemical compound used as a reference standard of API Medroxyprogesterone. The standard offered is compliant with regulatory guidelines. Medroxyprogesterone acetate-13C2-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 71-58-9 (non-labelled)
